Integrated regulatory models for inference of subtype‐specific susceptibilities in glioblastoma

• Main Authors: Yunpeng Liu, Ning Shi, Aviv Regev, Shan He, Michael T Hemann
• Format: Article
• Language: English
• Published: Wiley 2020-09-01
• Series: Molecular Systems Biology
• Subjects: cell state plasticity; gene essentiality inference; glioblastoma multiforme; subtype‐specific gene regulation; transcription regulatory networks
• Online Access: https://doi.org/10.15252/msb.20209506

Abstract Glioblastoma multiforme (GBM) is a highly malignant form of cancer that lacks effective treatment options or well‐defined strategies for personalized cancer therapy. The disease has been stratified into distinct molecular subtypes; however, the underlying regulatory circuitry that gives rise to such heterogeneity and its implications for therapy remain unclear. We developed a modular computational pipeline, Integrative Modeling of Transcription Regulatory Interactions for Systematic Inference of Susceptibility in Cancer (inTRINSiC), to dissect subtype‐specific regulatory programs and predict genetic dependencies in individual patient tumors. Using a multilayer network consisting of 518 transcription factors (TFs), 10,733 target genes, and a signaling layer of 3,132 proteins, we were able to accurately identify differential regulatory activity of TFs that shape subtype‐specific expression landscapes. Our models also allowed inference of mechanisms for altered TF behavior in different GBM subtypes. Most importantly, we were able to use the multilayer models to perform an in silico perturbation analysis to infer differential genetic vulnerabilities across GBM subtypes and pinpoint the MYB family member MYBL2 as a drug target specific for the Proneural subtype.